Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for National Healthcare (NHC) over the last 16 years, with FY2024 value amounting to $42.0 million.

  • National Healthcare's Depreciation & Amortization (CF) rose 507.58% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.6 million, marking a year-over-year increase of 539.34%. This contributed to the annual value of $42.0 million for FY2024, which is 11.66% down from last year.
  • As of FY2024, National Healthcare's Depreciation & Amortization (CF) stood at $42.0 million, which was down 11.66% from $42.0 million recorded in FY2023.
  • In the past 5 years, National Healthcare's Depreciation & Amortization (CF) ranged from a high of $42.0 million in FY2023 and a low of $40.5 million during FY2022
  • Its 5-year average for Depreciation & Amortization (CF) is $41.4 million, with a median of $42.0 million in 2024.
  • In the last 5 years, National Healthcare's Depreciation & Amortization (CF) tumbled by 320.34% in 2021 and then skyrocketed by 381.59% in 2023.
  • Over the past 5 years, National Healthcare's Depreciation & Amortization (CF) (Annual) stood at $42.0 million in 2020, then fell by 3.2% to $40.7 million in 2021, then fell by 0.45% to $40.5 million in 2022, then rose by 3.82% to $42.0 million in 2023, then decreased by 0.12% to $42.0 million in 2024.
  • Its Depreciation & Amortization (CF) was $42.0 million in FY2024, compared to $42.0 million in FY2023 and $40.5 million in FY2022.